Retraction

DMA, a Bisbenzimidazole, Offers Radioprotection by Promoting NFkB Transactivation through NIK/IKK in Human Glioma Cells

Citations (9)

9
Total Citations
1
Post-Retraction
(11.1%)
5
Pre-Retraction
1
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
0 Within 1 year
1 After 2+ years
1581 Days since retraction (latest)
Paper citing DMA, a Bisbenzimidazole, Offers Radioprotection by...
Unknown Authors
Unknown Journal
Published: Unknown
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing DMA, a Bisbenzimidazole, Offers Radioprotection by...
Unknown Authors
Unknown Journal
Published: Oct 2024
1581 days after retraction
Paper citing DMA, a Bisbenzimidazole, Offers Radioprotection by...
Unknown Authors
Unknown Journal
Published: Jun 2020
Same day as retraction
YAP Expression and Activity Are Suppressed by S100A7 via p65/NFκB-mediated Repression of ΔNp63
Yunguang Li, Fei Kong, Qirui Shao et al. (9 authors)
Molecular Cancer Research Open Access
Published: Sep 2017
12 citations
988 days before retraction
Paper citing DMA, a Bisbenzimidazole, Offers Radioprotection by...
Unknown Authors
Unknown Journal
Published: Jul 2017
1068 days before retraction
Paper citing DMA, a Bisbenzimidazole, Offers Radioprotection by...
Unknown Authors
Unknown Journal
Published: Jan 2016
1591 days before retraction
Paper citing DMA, a Bisbenzimidazole, Offers Radioprotection by...
Unknown Authors
Unknown Journal
Published: Aug 2015
1766 days before retraction
Paper citing DMA, a Bisbenzimidazole, Offers Radioprotection by...
Unknown Authors
Unknown Journal
Published: May 2013
2588 days before retraction